InvestorsObserver
×
News Home

DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference

Thursday, May 09, 2024 06:15 PM | PR Newswire via QuoteMedia

Mentioned in this article

DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference
DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference

PR Newswire

DENVER , May 9, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman , and its group vice president of investor relations, Nic Eliason , will participate in a fireside chat with investors at BofA Securities 2024 Health Care Conference on Tuesday, May 14th, 2024 at 5:00 pm Pacific Daylight Time .

To view the live webcast, visit the BofA page and create a free registration.

About DaVita Inc.

DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of March 31, 2024 , DaVita served approximately 258,600 patients at 3,092 outpatient dialysis centers, of which 2,665 centers were located in the United States and 427 centers were located in 12 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About .

Contact Information
IR@davita.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/davita-inc-to-participate-in-the-bofa-securities-2024-health-care-conference-302141845.html

SOURCE DaVita

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App